# # # #

MEDtalks: kort faglig opdatering

Hør kollegaer / specialister berette kort om specifikke emner med relevans for patientbehandling indenfor Almen praksis, Onkologer, Hæmatologer, osv.

Almen praksis

13:00

Optimering af NOAK-behandling: Individuelle overvejelser

Før valg og optimering af NOAK-behandling, er der en række indivi…

<script src="https://fast.wistia.com/embed/medias/ri338tt9uy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ri338tt9uy seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ri338tt9uy/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:36

Hvilke af dine patienter skal have AK-behandling

AK-behandling reducerer risikoen for iskæmisk apopleksi med 2/3  

<script src="https://fast.wistia.com/embed/medias/radc6puxbd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_radc6puxbd seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/radc6puxbd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:10

Atrieflimren hos patienten med apopleksi

Overlæge Thomas Truelsen, Neurologisk afdeling, Rigshospitalet, re…

<script src="https://fast.wistia.com/embed/medias/qabsn4m4ti.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qabsn4m4ti seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/qabsn4m4ti/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:48

Reducerer recidivrisikoen ved venøs tromboembolisk sygdom

Jørn Dalsgaard Nielsen, leder af Videncenter for Antikoagulant Beh…

<script src="https://fast.wistia.com/embed/medias/j8ftu85bei.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j8ftu85bei seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/j8ftu85bei/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
10:45

Svær lungeemboli – forebyggelse, behandling og kontrol

Jørn Dalsgaard Nielsen, leder af Videncenter for Antikoagulant Beh…

<script src="https://fast.wistia.com/embed/medias/wsk0p6fhaw.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wsk0p6fhaw seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/wsk0p6fhaw/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
10:36

Bedre forebyggelse ved venøs tromboembolisk sygdom

Jørn Dalsgaard Nielsen, leder af Videncenter for Antikoagulant Beh…

<script src="https://fast.wistia.com/embed/medias/hew7xhzskc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hew7xhzskc seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/hew7xhzskc/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:36

Inhalations-corticosteroid (ICS) ved KOL - hvilke patienter skal behandles og hvornår?

Igennem de senere Ã¥r er antallet af KOL-patienter i behandling med…

<script src="https://fast.wistia.com/embed/medias/yjrj16isj5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yjrj16isj5 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yjrj16isj5/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:34

Trelegy data - hvad viser studierne

Hvilken klinisk effekt kan du opnÃ¥ ved at behandle med fasttrestof…

<script src="https://fast.wistia.com/embed/medias/skihq5pul4.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_skihq5pul4 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/skihq5pul4/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:01

Ny klasse: fast triple kombinationsbehandling ved KOL – hvordan skal de anvendes?

I denne MEDtalk fÃ¥r du viden om, hvornÃ¥r man kan anvende den nye …

<script src="https://fast.wistia.com/embed/medias/jwcr4mxkzu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jwcr4mxkzu seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jwcr4mxkzu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
7:25

Tilskuddet til medicin mod astma og KOL ændres

Den 19. november 2018 ændrer Lægemiddelstyrelsen tilskuddet til n…

<script src="https://fast.wistia.com/embed/medias/oo3ir66m8i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_oo3ir66m8i seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/oo3ir66m8i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
7.40

God behandling af hjertesvigt i almen praksis

Hos lægerne i Vildbjerg anvender sygeplejerskerne et enkelt og pra…

<script src="https://fast.wistia.com/embed/medias/jn0dd5wnk8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jn0dd5wnk8 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jn0dd5wnk8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:40

Skal NOAC patienter bridges ved operationer?

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/9g2ayqgvr9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9g2ayqgvr9 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9g2ayqgvr9/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
13:01

Blødninger under AK-behandling

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/zn8e0mjevd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zn8e0mjevd seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/zn8e0mjevd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
13:06

Praktisk håndtering af AK-behandling

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/hraiv05z1u.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hraiv05z1u seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/hraiv05z1u/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
8:15

Atopic dermatitis – a clinical update

I en ny MEDtalk fortæller docent Anita Remitz, speciallæge i derm…

<script src="https://fast.wistia.com/embed/medias/5i5la6jicu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_5i5la6jicu videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/5i5la6jicu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
9:43

Spørgsmål til de nye diabetes guidelines

Overlæge Ole Snorgaard, Endokrinologisk Afdeling,…

<script src="https://fast.wistia.com/embed/medias/ovu2ngxiyl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ovu2ngxiyl videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ovu2ngxiyl/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:28

Ordination af inhalationssteroid ved KOL

Inhalationssteroid var engang et af de primære lægemid…

<script src="https://fast.wistia.com/embed/medias/1qw38y1fgl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1qw38y1fgl videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1qw38y1fgl/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
14:34

Nye reviderede guidelines for behandling af type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/6gqxos4cqy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6gqxos4cqy videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6gqxos4cqy/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:14

Henvisning af patienter med søvnforstyrrelser

I denne MEDtalk gør Poul Jennum, Søvncenteret i Glostrup, det kla…

<script src="https://fast.wistia.com/embed/medias/20xqq47tfa.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_20xqq47tfa videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/20xqq47tfa/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:26

Søvnproblemer kan føre til fratagelse af kørekort

En lang række faktorer kan pÃ¥virke bevidstheden og dermed evnen t…

<script src="https://fast.wistia.com/embed/medias/bk5q7fr3w8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_bk5q7fr3w8 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/bk5q7fr3w8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
7:33

10-15% af alle voksne rammes af søvnapnø

Søvnapnø er en hyppig lidelse, som mange patienter lever ubehandl…

<script src="https://fast.wistia.com/embed/medias/8lv1vsra5z.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_8lv1vsra5z videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/8lv1vsra5z/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:16

Søvnens betydning

Søvn handler om langt mere end at vÃ¥gne frisk om morgenen, for en…

<script src="https://fast.wistia.com/embed/medias/q5cl94y6pj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_q5cl94y6pj videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/q5cl94y6pj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
7:30

Spørgsmål om KOL fra dine kolleger

I denne MEDtalk svarer Nina Godfredsen pÃ¥ spørgsmÃ¥l fra dine kol…

<script src="https://fast.wistia.com/embed/medias/dsclm5if7i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_dsclm5if7i videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/dsclm5if7i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:20

Vælg den rigtige inhalator til dine patienter

Hvis dine patienters KOL-medicin skal virke optimalt, sÃ¥ gælder d…

<script src="https://fast.wistia.com/embed/medias/oa5lk9zwvh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_oa5lk9zwvh videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/oa5lk9zwvh/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:30

SÃ¥dan behandler du KOL

Behandling af KOL er blevet meget mere enkel og praktisk for dig so…

<script src="https://fast.wistia.com/embed/medias/xsha69igv7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xsha69igv7 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xsha69igv7/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
9:13

Vaccination mod influenza hos rejsende

Flere steder i verden kan man blive smittet af influenza hele Ã¥ret, …

<script src="https://fast.wistia.com/embed/medias/gl6zv1zcej.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gl6zv1zcej videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gl6zv1zcej/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:58

Vaccination mod tyfus

Det skønnes at op mod 20 millioner mennesker Ã¥rligt rammes af tyfus…

<script src="https://fast.wistia.com/embed/medias/azud4n1pg3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_azud4n1pg3 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/azud4n1pg3/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
18:02

Betydningen af søvn

Hør overlæge og professor Poul Jennum, Dansk Center for Søvnmedi…

<script src="https://fast.wistia.com/embed/medias/aa7uv5b4rg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_aa7uv5b4rg videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/aa7uv5b4rg/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:19

Hjertesvigt – kontrol i almen praksis

Hør hvordan du udreder og kontrollerer patienter med hjertesvigt. …

<script src="https://fast.wistia.com/embed/medias/4egh4g9x68.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4egh4g9x68 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/4egh4g9x68/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:49

Inddeling af patienter

Overlæge Morten Schou præsenterer her den typiske sygehistorie fo…

<script src="https://fast.wistia.com/embed/medias/9ueo3v2n5z.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9ueo3v2n5z videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9ueo3v2n5z/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:41

Hjertesvigt – forlæng livet og forebyg indlæggelser

Ny behandlingsmulighed gør, at flere af dine patienter med hjertes…

<script src="https://fast.wistia.com/embed/medias/gdaf1wbgx6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gdaf1wbgx6 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gdaf1wbgx6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:19

Hurtigere diagnostik af myelomatose

Med ganske fÃ¥ virkemidler er det muligt at afgøre, om dine patien…

<script src="https://fast.wistia.com/embed/medias/vlld4boamp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vlld4boamp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
27:26

Nye forenklede retningslinjer for KOL-behandling

KOL er den sygdom i Danmark, der bidrager mest til social ulighed i…

<script src="https://fast.wistia.com/embed/medias/a8rcb23vzo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_a8rcb23vzo videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/a8rcb23vzo/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:28

Myelomatose – materialer der kan hjælpe patient og pårørende

Myelomatose Foreningen har diverse støttematerialer, der kan være…

<script src="https://fast.wistia.com/embed/medias/j7lf7atgdj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j7lf7atgdj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:45

Myelomatose – en reminder til at hjælpe i udredningen

Her fÃ¥r du viden om en god reminder lavet af Myelomatose Foreninge…

<script src="https://fast.wistia.com/embed/medias/2upk7gfomy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2upk7gfomy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:40

Myelomatose - en sygdom der let overses

Myelomatose, en ikke-kurabel hæmatologisk sygdom, hvis symptomer e…

<script src="https://fast.wistia.com/embed/medias/xq3bn7xp0s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xq3bn7xp0s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
20:50

Forekomst og behandling af kardiovaskulær sygdom hos diabetespatienter i almen praksis

En ny dansk undersøgelse viser, at et stort antal diabetespatiente…

<script src="https://fast.wistia.com/embed/medias/0xvytwmqjy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xvytwmqjy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:55

Kontrol i almen praksis efter ablation

NÃ¥r patienter med atrieflimren har fÃ¥et foretaget ablation, udskr…

<script src="https://fast.wistia.com/embed/medias/lexvg7knyo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lexvg7knyo videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:07

Diabetisk nefropati - Farmakologisk behandling

Søren Tang Knudsen, overlæge pÃ¥ Medicinsk Endokrinologisk afdeli…

<script src="https://fast.wistia.com/embed/medias/g1oss1f9hm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_g1oss1f9hm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:43

Diabetisk nyresygdom og mikroalbuminuri - Forebyggelse og behandling

I dette andet modul af MEDtalk’en om Diabetisk nyresygdom og mikr…

<script src="https://fast.wistia.com/embed/medias/f1svl50kls.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f1svl50kls videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:34

Diabetisk nyresygdom og mikroalbuminuri - Screening og naturhistorie

Med fokus pÃ¥ screening og naturhistorie vil Søren Tang Knudsen, o…

<script src="https://fast.wistia.com/embed/medias/0z1hbge3d8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0z1hbge3d8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:36

Hvad skal få mig, som læge, til at tænke ADHD?

I denne MEDtalk beskriver speciallæge i børne-/ungepsykiatri Jaco…

<script src="https://fast.wistia.com/embed/medias/yji6kccwys.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yji6kccwys videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:43

Spørgsmål fra almen praksis om type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/j69ca6c5pz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j69ca6c5pz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:34

Valg af behandling når patienten har type 2-diabetes og hjertesygdom

<script src="https://fast.wistia.com/embed/medias/m97eojk57i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_m97eojk57i videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:14

Klassiske senkomplikationer ved type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/64ekomhzrm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_64ekomhzrm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
27:55

Ablationsbehandling af atrieflimren – Hvem, hvornår og hvordan?

<script src="https://fast.wistia.com/embed/medias/2na6xy142g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2na6xy142g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:16

Spørgsmål til hvordan man reducerer forbruget af steroid hos KOL patienter

Pensioneret praktiserende læge, nu lægevikar Mogens Jacobsen svar…

<script src="https://fast.wistia.com/embed/medias/3p9obtegfn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3p9obtegfn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:45

Behandlingen af KOL patienter

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/6jyygwwhzz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6jyygwwhzz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:44

Gode grunde til at seponere inhalationssteroid

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/px72uhb0tr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_px72uhb0tr videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:31

Algoritme for behandling ved type 2-diabetes

I dette modul redegør Søren Tang Knudsen for fordele og ulemper v…

<script src="https://fast.wistia.com/embed/medias/aj9h298coq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_aj9h298coq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:17

Valg af diabetes behandling

Den medicinske behandling er hjørnestenen i den kliniske indsats v…

<script src="https://fast.wistia.com/embed/medias/6mfzajylqm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6mfzajylqm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:05

Nytter livsstilsændringer ved type 2-diabetes?

Det er meget svært at ændre sin livsstil. Derfor er de…

<script src="https://fast.wistia.com/embed/medias/3s61uveub3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3s61uveub3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
07:09

Multifarmakologisk intervention ved Type 2-diabetes

Vi ved at god glykæmisk…

<script src="https://fast.wistia.com/embed/medias/zeh13v5hxy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zeh13v5hxy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:31

Effekten af kirurgisk behandling

Der er indikation for kirurgisk behandling af svær over…

<script src="https://fast.wistia.com/embed/medias/rnqbwfhkxn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rnqbwfhkxn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:31

Effekten af farmakologisk behandling

Hvordan virker medicinsk…

<script src="https://fast.wistia.com/embed/medias/b0l13lf5mx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b0l13lf5mx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Effekten af livsstilsintervention

Hvilken kostændring er bedst i forhold til at reducere sin kropsvÅ

<script src="https://fast.wistia.com/embed/medias/d40wykyohg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_d40wykyohg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:07

Hvordan udvikles svær overvægt

Overvægt handler ikke kun om, at man spiser mere, end man forbruge…

<script src="https://fast.wistia.com/embed/medias/xevhvj7ls6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xevhvj7ls6 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Medicinsk støtte til vægttab

Der 3 muligheder for medicinsk behandling af overvægt, som gennemg…

<script src="https://fast.wistia.com/embed/medias/r4a9xqak6l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_r4a9xqak6l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
12:56

Patientdialog om vægttabsforløb

Praktiserende læge Pia Müller har en dialog med en af sine patien…

<script src="https://fast.wistia.com/embed/medias/tiln0l9b17.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tiln0l9b17 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:23

Tips og tricks til patientforløb om vægttab

SpørgsmÃ¥l til Pia Müller om tips og tricks til patientforløb om…

<script src="https://fast.wistia.com/embed/medias/cz7t3vw7oa.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_cz7t3vw7oa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Komorbiditet og fysisk aktivitet ved overvægt

I dette modul gennemgÃ¥r praktiserende læge Pia Müller de hyppigs…

<script src="https://fast.wistia.com/embed/medias/3b5gfwkiha.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3b5gfwkiha videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Motivation til vægttab

Motivation er alfa og omega for adfærdsændringer og dermed ogsÃ¥ …

<script src="https://fast.wistia.com/embed/medias/xr46gplt6x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xr46gplt6x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Hvordan reduceres steroidforbruget hos patienter med KOL?

<script src="https://fast.wistia.com/embed/medias/tjn0xyrl7x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tjn0xyrl7x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:48

NÃ¥r diabetespatienten har hjertesygdom og hjertepatienten har diabetes

Patienter med diabetes har fortsat 50-60 % overdødeligh…

<script src="https://fast.wistia.com/embed/medias/ya9ymgx2gw.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ya9ymgx2gw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:57

Malaria

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/0xkkd46yry.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xkkd46yry videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:36

Rejsediarre

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/3hdrai9sio.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3hdrai9sio videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Rejsevaccination

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/2wyver70bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2wyver70bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Hepatitis A og B

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/716satyxgp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_716satyxgp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
02:52

Hjælpemidler til tjek af inhalationsteknik

Der findes forskellige hjælpemidler, der kan give en indikation af…

<script src="https://fast.wistia.com/embed/medias/qg6r27lwvv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qg6r27lwvv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
05:23

Valg af inhalator

Husk at meget medicin findes i flere forskellige inhalatorer – vÅ

<script src="https://fast.wistia.com/embed/medias/65vtwhwwlg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_65vtwhwwlg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:36

KOL og udfordringer med inhalationsteknik

Vi følger guidelines, men glemmer tit at tjekke det væsentlige: k…

<script src="https://fast.wistia.com/embed/medias/3qsk69sg11.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3qsk69sg11 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
06:24

De forskellige inhalatorer

Har du overblik? Der findes mange forskellige inhalatorer med den s…

<script src="https://fast.wistia.com/embed/medias/19jel19618.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_19jel19618 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 2:25

Ny lysbehandling til patienter med plaque psoriasis

Verdens første fototerapi til behandling af mild til moderat plaque p…

<script src="https://fast.wistia.com/embed/medias/kjl998ujwy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kjl998ujwy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Blue Light og forskning

I dette modul af BestPractice MEDtalk om Philips Blue Light teknolo…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i dette modul af BestPractice MEDtalk…

<script src="https://fast.wistia.com/embed/medias/o6ebt6z3s9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6ebt6z3s9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Klinisk dokumentation

I dette modul af BestPractice Medtalk gennemgÃ¥r Professor Matthias…

<script src="https://fast.wistia.com/embed/medias/qpwlz04pd0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qpwlz04pd0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Kistrup MEDtalk 30. maj 2017 21:31

Type 2-diabetes hos patienter med anden etnisk baggrund

Forekomsten af type 2-diabetes blandt eksempelvis efterkommere fra …

<script src="https://fast.wistia.com/embed/medias/30di3i0oad.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_30di3i0oad videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
17:56

Nye GOLD-guidelines

GOLD-guidelines til behandling af KOL er blevet opdateret me…

<script src="https://fast.wistia.com/embed/medias/mue93jhp0n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mue93jhp0n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:47

Risikoen for stroke er vigtigere end for blødning

Risikoen for stroke er vigtigst AK-behandling er e…

<script src="https://fast.wistia.com/embed/medias/qqwddu8n5s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qqwddu8n5s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:56

Pas på med reduceret AK-dosis

Pas pÃ¥ med reduceret AK-dosis Det kan være frist…

<script src="https://fast.wistia.com/embed/medias/9ommd7u19c.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9ommd7u19c videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:52

Er warfarin og NOAK lige gode?

NOAK virker samlet set bedre end warfarin Studier,…

<script src="https://fast.wistia.com/embed/medias/891apdxyto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_891apdxyto videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:00

Tryghed i din AK-behandling

Hør Torben Bjerregaard Larsen give pra…

<script src="https://fast.wistia.com/embed/medias/qyc92bz7vx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qyc92bz7vx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:28

Levetiden er forkortet med op til 12 år ved type 2-diabetes

Omkring 2/3 af diabetespatienterne over 65 Ã¥r dør af hjerte-karsygdo…

<script src="//fast.wistia.com/embed/medias/49eeiaamqu.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_49eeiaamqu videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:48

Reduceret kardiovaskulær mortalitet

Ved at ændre behandlingen af type 2-diabetes er det muligt at reducer…

<script src="//fast.wistia.com/embed/medias/efrp0405nm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_efrp0405nm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:25

GLP-1 analog med kardiovaskulær beskyttende effekt

Nye resultater viser, at der er flere behandlingsmuligheder for at opn…

<script src="//fast.wistia.com/embed/medias/287pnsxzty.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_287pnsxzty videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Paradigme skift i behandling af type 2-diabetes og hjerte-kar-sygdom

Hør Kenneth Egstrup fortælle om, hvorfor han mener, at vi stÃ¥r over…

<script src="//fast.wistia.com/embed/medias/umcl212b6s.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_umcl212b6s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
14:14

Behandlingsmuligheder ved svær overvægt

Forekomsten af svær overvægt er steget ganske betydeligt de senes…

<script src="//fast.wistia.com/embed/medias/e6o325u671.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e6o325u671 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan fÃ¥ et mere stabilt blodsukkerniveau, hvis du v…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

AK-behandling ved AF

100.000 patienter i Danmark er i AK-behandling som følg…

<script src="//fast.wistia.com/embed/medias/2axxdw02fa.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2axxdw02fa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Uffe Bødtger MEDtalk BestPractice 3:05

SÃ¥dan seponerer du inhalationssteroid ved KOL

Der har de senere Ã¥r været fokus pÃ¥ …

<script src="//fast.wistia.com/embed/medias/au5f0929j0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_au5f0929j0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan fÃ¥ et mere stabilt blodsukkerniveau, hvis du vælg…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jens Friberg MEDtalk BestPractice 5:33

Valg af AK-behandling ved AF? - Jens Friberg

100.000 patienter i Danmark er i AK-behandling som følg…

<script src="//fast.wistia.com/embed/medias/2axxdw02fa.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2axxdw02fa videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Uffe Bødtker MEDtalk BestPractice 3:04

SÃ¥dan seponerer du inhalationssteroid ved KOL

Der har de senere Ã¥r været fokus pÃ¥ …

<script src="//fast.wistia.com/embed/medias/au5f0929j0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_au5f0929j0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Kenneth Egstrup BestPractice webinar 27:40

Behandling af kardiovaskulær sygdom og samtidig type 2-diabetes

<script src="//fast.wistia.com/embed/medias/3mmlrprgmj.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3mmlrprgmj videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jens Friberg AK-behandling - Nye resultater fra almen praksis 19:20

AK-behandling - Nye resultater fra almen praksis

Omkring 100.000 patienter i Danmark er i AK-behandling som følge a…

<script src="//fast.wistia.com/embed/medias/pjyigjk724.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pjyigjk724 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll 26:30

Nye insuliner og kombinationsmuligheder

Antallet af glukosereducerende lægemidler har været stærkt stige…

<script src="//fast.wistia.com/embed/medias/imve6n5pqs.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_imve6n5pqs videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
22:48

Nye resultater ved KOL-behandling

Grundstammen i KOL-behandling er inhaleret bronkodilatator, men man…

<script src="//fast.wistia.com/embed/medias/2vur541hg2.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2vur541hg2 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Ulrik Pedersen-Bjergaard 25:27

Hypoglykæmi ved type 2-diabetes - set i patientperspektiv

Hypoglykæmi ved type 2-diabetes er en bivirkning til behandlingen,…

<script src="//fast.wistia.com/embed/medias/w5au0wvmga.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_w5au0wvmga videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Pernille Corell 22:10

Balancér blødningsrisiko og AK-behandling

Vi har talt med praktiserende læger om blødningsrisiko og AK-beha…

<script src="//fast.wistia.com/embed/medias/pbq4agscr5.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script> <div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pbq4agscr5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Ander Løkke 33:31

Optimal terapivalg ved KOL - ICS, LABA og/eller LAMA

Optimal terapivalg ved KOL – ICS, LABA og/eller LAMA KOL er en af d…

<script src="//fast.wistia.com/embed/medias/vftsd6wf2j.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vftsd6wf2j videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Bruun Abild og Bjørn Richelsen MEDtalk BestPractice 25:41

Påvirk vægten ved diabetes

<script src="//fast.wistia.com/embed/medias/n29oakz1nc.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_n29oakz1nc videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Uffe Bødtker 23:05

Optimér kombinationerne i KOL-behandlingen

Flere hundrede præparater og behandlingskombinationer til KOL er e…

<script src="//fast.wistia.com/embed/medias/04xm2c2yyw.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_04xm2c2yyw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Steen Madsbad 35:29

Nyt om antidiabetika og CV-risiko. Hvad viser de nyeste studier?

Øger antidiabetika den kardiovaskulære risiko? Patienter med diab…

<script src="//fast.wistia.com/embed/medias/r1a80p1axp.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_r1a80p1axp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Bestpractice webinar med Ulrik Pedersen-Bjergaard og Hanne Holdflod Nørgaard 21:30

Kørekort og diabetes - overblik og praktiske tips

Reglerne er en balancegang for bÃ¥de læge og patient, specielt m.h…

<script src="//fast.wistia.com/embed/medias/1hz8mhu1ux.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1hz8mhu1ux videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Jørgen Rungby 37:14

SÃ¥dan behandler du individuelt diabetes og hjerte-kar-sygdom

Patienter med diabetes har en generel øget risiko for at udvikle h…

<script src="//fast.wistia.com/embed/medias/p4d50hta0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p4d50hta0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Jørgen Rungby MEDtalk BestPractice 25:22

Nyren og diabetes

<script src="//fast.wistia.com/embed/medias/vq9lbob7g8.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vq9lbob7g8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med Pernille Corell 41:42

Kolesterolsænkning - the lower the better?

Der er solid dokumentation for, at reduktion af LDL-niveauet reduce…

<script src="//fast.wistia.com/embed/medias/afw6q7ohu4.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_afw6q7ohu4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Apoteket

5:40

Skal NOAC patienter bridges ved operationer?

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/9g2ayqgvr9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9g2ayqgvr9 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9g2ayqgvr9/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
13:01

Blødninger under AK-behandling

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/zn8e0mjevd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zn8e0mjevd seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/zn8e0mjevd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
13:06

Praktisk håndtering af AK-behandling

Jess Lambrechtsen, overlæge kardiologisk afdeling OUH-Svendborg, f…

<script src="https://fast.wistia.com/embed/medias/hraiv05z1u.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hraiv05z1u seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/hraiv05z1u/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
8:15

Atopic dermatitis – a clinical update

I en ny MEDtalk fortæller docent Anita Remitz, speciallæge i derm…

<script src="https://fast.wistia.com/embed/medias/5i5la6jicu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_5i5la6jicu videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/5i5la6jicu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
9:13

Vaccination mod influenza hos rejsende

Flere steder i verden kan man blive smittet af influenza hele Ã¥ret, …

<script src="https://fast.wistia.com/embed/medias/gl6zv1zcej.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gl6zv1zcej videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gl6zv1zcej/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:58

Vaccination mod tyfus

Det skønnes at op mod 20 millioner mennesker Ã¥rligt rammes af tyfus…

<script src="https://fast.wistia.com/embed/medias/azud4n1pg3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_azud4n1pg3 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/azud4n1pg3/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:36

Hvad skal få mig, som læge, til at tænke ADHD?

I denne MEDtalk beskriver speciallæge i børne-/ungepsykiatri Jaco…

<script src="https://fast.wistia.com/embed/medias/yji6kccwys.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yji6kccwys videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:14

Klassiske senkomplikationer ved type 2-diabetes

<script src="https://fast.wistia.com/embed/medias/64ekomhzrm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_64ekomhzrm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:44

Gode grunde til at seponere inhalationssteroid

Pensioneret praktiserende læge, nu lægevikar, Mogens Jacobsen gen…

<script src="https://fast.wistia.com/embed/medias/px72uhb0tr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_px72uhb0tr videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
08:05

Nytter livsstilsændringer ved type 2-diabetes?

Det er meget svært at ændre sin livsstil. Derfor er de…

<script src="https://fast.wistia.com/embed/medias/3s61uveub3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3s61uveub3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:44

Effekten af livsstilsintervention

Hvilken kostændring er bedst i forhold til at reducere sin kropsvÅ

<script src="https://fast.wistia.com/embed/medias/d40wykyohg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_d40wykyohg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:49

Motivation til vægttab

Motivation er alfa og omega for adfærdsændringer og dermed ogsÃ¥ …

<script src="https://fast.wistia.com/embed/medias/xr46gplt6x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xr46gplt6x videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:57

Malaria

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/0xkkd46yry.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0xkkd46yry videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:36

Rejsediarre

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/3hdrai9sio.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3hdrai9sio videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Rejsevaccination

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/2wyver70bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2wyver70bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:03

Hepatitis A og B

Gennem fire moduler giver Carsten Schade Larsen, dr. med, overlæge…

<script src="https://fast.wistia.com/embed/medias/716satyxgp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_716satyxgp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
02:52

Hjælpemidler til tjek af inhalationsteknik

Der findes forskellige hjælpemidler, der kan give en indikation af…

<script src="https://fast.wistia.com/embed/medias/qg6r27lwvv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qg6r27lwvv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
05:23

Valg af inhalator

Husk at meget medicin findes i flere forskellige inhalatorer – vÅ

<script src="https://fast.wistia.com/embed/medias/65vtwhwwlg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_65vtwhwwlg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:36

KOL og udfordringer med inhalationsteknik

Vi følger guidelines, men glemmer tit at tjekke det væsentlige: k…

<script src="https://fast.wistia.com/embed/medias/3qsk69sg11.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3qsk69sg11 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
06:24

De forskellige inhalatorer

Har du overblik? Der findes mange forskellige inhalatorer med den s…

<script src="https://fast.wistia.com/embed/medias/19jel19618.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_19jel19618 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 2:25

Ny lysbehandling til patienter med plaque psoriasis

Verdens første fototerapi til behandling af mild til moderat plaque p…

<script src="https://fast.wistia.com/embed/medias/kjl998ujwy.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kjl998ujwy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Caroline Kistrup MEDtalk 30. maj 2017 21:31

Type 2-diabetes hos patienter med anden etnisk baggrund

Forekomsten af type 2-diabetes blandt eksempelvis efterkommere fra …

<script src="https://fast.wistia.com/embed/medias/30di3i0oad.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_30di3i0oad videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
17:56

Nye GOLD-guidelines

GOLD-guidelines til behandling af KOL er blevet opdateret me…

<script src="https://fast.wistia.com/embed/medias/mue93jhp0n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mue93jhp0n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:47

Risikoen for stroke er vigtigere end for blødning

Risikoen for stroke er vigtigst AK-behandling er e…

<script src="https://fast.wistia.com/embed/medias/qqwddu8n5s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qqwddu8n5s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:52

Er warfarin og NOAK lige gode?

NOAK virker samlet set bedre end warfarin Studier,…

<script src="https://fast.wistia.com/embed/medias/891apdxyto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_891apdxyto videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:28

Levetiden er forkortet med op til 12 år ved type 2-diabetes

Omkring 2/3 af diabetespatienterne over 65 Ã¥r dør af hjerte-karsygdo…

<script src="//fast.wistia.com/embed/medias/49eeiaamqu.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_49eeiaamqu videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:48

Reduceret kardiovaskulær mortalitet

Ved at ændre behandlingen af type 2-diabetes er det muligt at reducer…

<script src="//fast.wistia.com/embed/medias/efrp0405nm.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_efrp0405nm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tina Vilsbøll MEDtalk BestPractice 2:48

Nye basalinsuliner bedrer blodsukkerkontrollen

Dine patienter kan fÃ¥ et mere stabilt blodsukkerniveau, hvis du vælg…

<script src="//fast.wistia.com/embed/medias/f05u112ff0.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f05u112ff0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Dermatologi

2:59

EADV 2018: Nye aspekter ved immunterapi ved malign melanom

Christian Blank, The Netherlands Cancer Institute, er en af keynote…

<script src="https://fast.wistia.com/embed/medias/ayhcwb34bj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ayhcwb34bj videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ayhcwb34bj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:19

EADV 2018: Stigmatisering i dermatologien

Det er meget udbredt blandt dermatologiske patienter, at de oplever…

<script src="https://fast.wistia.com/embed/medias/0s3gniofpc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0s3gniofpc videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/0s3gniofpc/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:33

EADV 2018: Atopisk dermatitis i fokus på EADV

Kilian Eyerich, professor, Technical University of Munich, giver i …

<script src="https://fast.wistia.com/embed/medias/l7oqnuew23.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l7oqnuew23 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l7oqnuew23/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:10

EADV 2018: Vi kan gøre det endnu bedre

Med den revolution behandling af psoriasis og atypisk dermatitis ha…

<script src="https://fast.wistia.com/embed/medias/jj92ly3nxe.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jj92ly3nxe videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jj92ly3nxe/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:47

EADV 2018: EADV 2018 afspejler et speciale i transmission

Jørgen Serup, overlæge, professor, Bispebjerg Hospital, (DK), giv…

<script src="https://fast.wistia.com/embed/medias/obdpyjzatt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_obdpyjzatt videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/obdpyjzatt/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:10

EADV 2018: Onykoskopi opdatering

Michela Starace, universitetet i Bologna, giver her en faglig opdat…

<script src="https://fast.wistia.com/embed/medias/mzlosx5dev.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mzlosx5dev videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/mzlosx5dev/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:51

EADV 2018: Vidner til en revolution for behandling af atopisk dermatitis

De senere Ã¥r har givet os en forstÃ¥else af patogenesen for atypis…

<script src="https://fast.wistia.com/embed/medias/2vwpt03yo7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2vwpt03yo7 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/2vwpt03yo7/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:04

EADV 2018: Behandlingsmålet for psoriasis ændrer sig

Med de nye behandlingsmuligheder for psoriasis vil vi i de kommende…

<script src="https://fast.wistia.com/embed/medias/yzcxdor3zo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yzcxdor3zo videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yzcxdor3zo/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:39

EADV 2018: Mød EADV Board member Jørgen Serup

Gennem mere end 25 Ã¥r har Jørgen Serup været en del af EADV, og …

<script src="https://fast.wistia.com/embed/medias/26x8yol2ns.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_26x8yol2ns videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/26x8yol2ns/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:59

EADV 2018: Nye aspekter ved immunterapi ved malign melanom

Christian Blank, The Netherlands Cancer Institute, er en af keynote…

<script src="https://fast.wistia.com/embed/medias/ayhcwb34bj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ayhcwb34bj videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ayhcwb34bj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

EADV 2018: Dyb videnskløft ved psoriasis

Rosa Parisi & Ireny Iskandar fra universitetet i Manchester (UK…

<script src="https://fast.wistia.com/embed/medias/1x6r362odr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1x6r362odr videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1x6r362odr/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:12

EADV 2018: Store forventninger til bred pipeline

FÃ¥ et indblik i hvilke angrebspunkter og virkningsmekanismer, der …

<script src="https://fast.wistia.com/embed/medias/lil6jsl9h8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lil6jsl9h8 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lil6jsl9h8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:13

EADV 2018: Nyt om IL-17 hæmmere ved behandling af psoriasis

Professor dr Marc Radtke, University Medical Center Hamburg- Eppend…

<script src="https://fast.wistia.com/embed/medias/9dlgyl0qyh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9dlgyl0qyh videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9dlgyl0qyh/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:06

EADV 2018: Nye behandlingsmuligheder ved psoriasis

BestPractice har bedt professor dr Marc Radtke, University Medical …

<script src="https://fast.wistia.com/embed/medias/tknfbdrlt8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tknfbdrlt8 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/tknfbdrlt8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:16

EADV 2018: Interessant med langtidsdata for behandling af atopisk dermatitis

Laura B. von Kobyletzki, läkare, med.dr, MSc , dermatologisk avdel…

<script src="https://fast.wistia.com/embed/medias/s6hzw57j82.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_s6hzw57j82 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/s6hzw57j82/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:17

EADV 2018: Fremtidens udfordringer ved behandling af atopisk dermatitis

En lang række nye behandlingsmuligheder til atopisk dermatitis er …

<script src="https://fast.wistia.com/embed/medias/9y94m82o1l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9y94m82o1l videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9y94m82o1l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:08

EADV 2018: Forventning om nye data og international networking

Ã…ke Svensson, docent og chef for Hudklinikken pÃ¥ Universitetssjuk…

<script src="https://fast.wistia.com/embed/medias/6o0jrmv29x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6o0jrmv29x videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6o0jrmv29x/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:59

EADV 2018: Livskvaliteten hos unge med acne skal bedres

Som dermatologer er vi interesserede i at hjælpe vo…

<script src="https://fast.wistia.com/embed/medias/3mqag8l0ty.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3mqag8l0ty videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/3mqag8l0ty/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
8:15

Atopic dermatitis – a clinical update

I en ny MEDtalk fortæller docent Anita Remitz, speciallæge i derm…

<script src="https://fast.wistia.com/embed/medias/5i5la6jicu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_5i5la6jicu videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/5i5la6jicu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:59

Svigt af standard immunterapi ved malign melanom

Patienter med metastaserende malign melanom, der ikke responderer suff…

<script src="https://fast.wistia.com/embed/medias/rjzf31xt2l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rjzf31xt2l videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Blue Light og forskning

I dette modul af BestPractice MEDtalk om Philips Blue Light teknolo…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i dette modul af BestPractice MEDtalk…

<script src="https://fast.wistia.com/embed/medias/o6ebt6z3s9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6ebt6z3s9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Klinisk dokumentation

I dette modul af BestPractice Medtalk gennemgÃ¥r Professor Matthias…

<script src="https://fast.wistia.com/embed/medias/qpwlz04pd0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qpwlz04pd0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Ny behandling til plaquepsoriasis

En ny type fototerapi fra Philips er udviklet til behandling af pla…

<script src="https://fast.wistia.com/embed/medias/wkt9vbsskl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wkt9vbsskl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

EADV 2018

2:59

EADV 2018: Nye aspekter ved immunterapi ved malign melanom

Christian Blank, The Netherlands Cancer Institute, er en af keynote…

<script src="https://fast.wistia.com/embed/medias/ayhcwb34bj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ayhcwb34bj videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ayhcwb34bj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:19

EADV 2018: Stigmatisering i dermatologien

Det er meget udbredt blandt dermatologiske patienter, at de oplever…

<script src="https://fast.wistia.com/embed/medias/0s3gniofpc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0s3gniofpc videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/0s3gniofpc/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:33

EADV 2018: Atopisk dermatitis i fokus på EADV

Kilian Eyerich, professor, Technical University of Munich, giver i …

<script src="https://fast.wistia.com/embed/medias/l7oqnuew23.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l7oqnuew23 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l7oqnuew23/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:10

EADV 2018: Vi kan gøre det endnu bedre

Med den revolution behandling af psoriasis og atypisk dermatitis ha…

<script src="https://fast.wistia.com/embed/medias/jj92ly3nxe.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jj92ly3nxe videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jj92ly3nxe/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:47

EADV 2018: EADV 2018 afspejler et speciale i transmission

Jørgen Serup, overlæge, professor, Bispebjerg Hospital, (DK), giv…

<script src="https://fast.wistia.com/embed/medias/obdpyjzatt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_obdpyjzatt videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/obdpyjzatt/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:10

EADV 2018: Onykoskopi opdatering

Michela Starace, universitetet i Bologna, giver her en faglig opdat…

<script src="https://fast.wistia.com/embed/medias/mzlosx5dev.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mzlosx5dev videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/mzlosx5dev/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:51

EADV 2018: Vidner til en revolution for behandling af atopisk dermatitis

De senere Ã¥r har givet os en forstÃ¥else af patogenesen for atypis…

<script src="https://fast.wistia.com/embed/medias/2vwpt03yo7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2vwpt03yo7 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/2vwpt03yo7/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:04

EADV 2018: Behandlingsmålet for psoriasis ændrer sig

Med de nye behandlingsmuligheder for psoriasis vil vi i de kommende…

<script src="https://fast.wistia.com/embed/medias/yzcxdor3zo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yzcxdor3zo videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yzcxdor3zo/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:39

EADV 2018: Mød EADV Board member Jørgen Serup

Gennem mere end 25 Ã¥r har Jørgen Serup været en del af EADV, og …

<script src="https://fast.wistia.com/embed/medias/26x8yol2ns.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_26x8yol2ns videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/26x8yol2ns/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:59

EADV 2018: Nye aspekter ved immunterapi ved malign melanom

Christian Blank, The Netherlands Cancer Institute, er en af keynote…

<script src="https://fast.wistia.com/embed/medias/ayhcwb34bj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ayhcwb34bj videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ayhcwb34bj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

EADV 2018: Dyb videnskløft ved psoriasis

Rosa Parisi & Ireny Iskandar fra universitetet i Manchester (UK…

<script src="https://fast.wistia.com/embed/medias/1x6r362odr.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1x6r362odr videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1x6r362odr/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:12

EADV 2018: Store forventninger til bred pipeline

FÃ¥ et indblik i hvilke angrebspunkter og virkningsmekanismer, der …

<script src="https://fast.wistia.com/embed/medias/lil6jsl9h8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lil6jsl9h8 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lil6jsl9h8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:13

EADV 2018: Nyt om IL-17 hæmmere ved behandling af psoriasis

Professor dr Marc Radtke, University Medical Center Hamburg- Eppend…

<script src="https://fast.wistia.com/embed/medias/9dlgyl0qyh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9dlgyl0qyh videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9dlgyl0qyh/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:06

EADV 2018: Nye behandlingsmuligheder ved psoriasis

BestPractice har bedt professor dr Marc Radtke, University Medical …

<script src="https://fast.wistia.com/embed/medias/tknfbdrlt8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tknfbdrlt8 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/tknfbdrlt8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:16

EADV 2018: Interessant med langtidsdata for behandling af atopisk dermatitis

Laura B. von Kobyletzki, läkare, med.dr, MSc , dermatologisk avdel…

<script src="https://fast.wistia.com/embed/medias/s6hzw57j82.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_s6hzw57j82 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/s6hzw57j82/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:17

EADV 2018: Fremtidens udfordringer ved behandling af atopisk dermatitis

En lang række nye behandlingsmuligheder til atopisk dermatitis er …

<script src="https://fast.wistia.com/embed/medias/9y94m82o1l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9y94m82o1l videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9y94m82o1l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:08

EADV 2018: Forventning om nye data og international networking

Ã…ke Svensson, docent og chef for Hudklinikken pÃ¥ Universitetssjuk…

<script src="https://fast.wistia.com/embed/medias/6o0jrmv29x.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6o0jrmv29x videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6o0jrmv29x/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:59

EADV 2018: Livskvaliteten hos unge med acne skal bedres

Som dermatologer er vi interesserede i at hjælpe vo…

<script src="https://fast.wistia.com/embed/medias/3mqag8l0ty.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3mqag8l0ty videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/3mqag8l0ty/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

Gastroenterologi

3:53

Effektvurdering ved opstart

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/3a59clzz8n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3a59clzz8n videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:21

Valg af behandling af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/nuls6tsqsb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_nuls6tsqsb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:33

Optimering af behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/5m6lwbm3ao.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_5m6lwbm3ao videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:37

MÃ¥l for behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/gvd82auyhm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gvd82auyhm videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:19

Nyt i behandlingen af IBD

Dr. Brian Bressler er clinical assistant professor indenfor gastroe…

<script src="https://fast.wistia.com/embed/medias/za3ggsejjv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_za3ggsejjv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Stefan Schreiber rebyggelse af sygdomsprogression 2:00

Forebyggelse af sygdomsprogression

I dette modul af BestPractice MEDtalk med Professor, ind…

<script src="https://fast.wistia.com/embed/medias/tl9v7px26s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tl9v7px26s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:15

Vedolizumab til behandling af Crohns sygdom samt Colitis Ulcerosa

I dette modul af BestPractice MEDtalk med Professor, i g…

<script src="https://fast.wistia.com/embed/medias/9in2l55v37.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9in2l55v37 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:57

Behandlingsskift – tid til at ordeinere noget andet?

Professor, i gastroenterologi, Stefan Schreiber fra Kiel…

<script src="https://fast.wistia.com/embed/medias/izdr9171ea.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_izdr9171ea videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:17

STRIDE og treat-to-target anbefalinger

I dette modul af BestPractice MEDtalk præsenterer Profe…

<script src="https://fast.wistia.com/embed/medias/h2u9fi6wfh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_h2u9fi6wfh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Hæmatologi

4:22

ASH 2018: Nyt lægemiddel mod svær Hæmofili A hos børn og unge på vej

Marianne Hoffmann, Børne-ungeklinikken, Rigshospitalet og Torben M…

<script src="https://fast.wistia.com/embed/medias/6vqk65hw5l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6vqk65hw5l seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6vqk65hw5l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:44

ASH 2018: Very exciting new data from the MURANO-study about treatment of relapsed/Refractory CLL

In this MEDtalk John Gribben, Professor, MD DSc,…

<script src="https://fast.wistia.com/embed/medias/z7n5c53sax.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_z7n5c53sax seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/z7n5c53sax/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:50

ASH 2018: Resultater fra HAVEN 3 og HAVEN 4

Hør denne MEDtalk hvor professor Víctor Jiménez Yuste, Head of H…

<script src="https://fast.wistia.com/embed/medias/f13u5no6fp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f13u5no6fp seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/f13u5no6fp/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:32

ASH 2018: ASH har oppdaget de nordiske lymfom-registere med real word evidence

I denne MEDtalk fortæller overlæge Tarec Christoffer El-Galaly, A…

<script src="https://fast.wistia.com/embed/medias/51smq4xae6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_51smq4xae6 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/51smq4xae6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:27

ASH 2018: Nyt om AML

I denne MEDtalk fortæller professor, overlæge Bjørn Tore Gjertse…

<script src="https://fast.wistia.com/embed/medias/qz64v5ds6j.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qz64v5ds6j seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/qz64v5ds6j/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:28

ASH 2018: Forbedret PFS med ibrutinib i førstelinje til patienter over 65 år

Hør professor Kerry Rogers, The Ohio State University, fortælle o…

<script src="https://fast.wistia.com/embed/medias/vc7tnccm9i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vc7tnccm9i seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/vc7tnccm9i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:46

ASH 2018: Forbedret PFS med Ibrutinib i førstelinje i to studier

I denne MEDtalk fortæller professor Kerry Rogers, The Ohio State U…

<script src="https://fast.wistia.com/embed/medias/6navi5zsqm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6navi5zsqm seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6navi5zsqm/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:32

ASH 2018: Nye data for Ibrutinib sætter nye standarder for CLL-behandlingen

Professor John Gribben, Barts Cancer Institute, London, præsentere…

<script src="https://fast.wistia.com/embed/medias/iq7anw7gva.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_iq7anw7gva seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/iq7anw7gva/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:13

ASH 2018: Overbevisende resultater for Darzalex i kombination med Revlimid og Dexamethason til ældre med myelomatoise

Resultaterne fra MAIA-studiet hvor ældre patienter med myelomatose…

<script src="https://fast.wistia.com/embed/medias/43o8nlhivp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_43o8nlhivp seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/43o8nlhivp/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:33

ASH 2018: Venetoclax-Rituximab Combination Therapy in Relapsed/Refractory CLL. Update data from MURANO study

In this MEDtalk John F. Seymour present the key data from MURANO st…

<script src="https://fast.wistia.com/embed/medias/yjpdwx8lv8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yjpdwx8lv8 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yjpdwx8lv8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:01

ASH 2018: Better Early Molecular Response and relapse free survival in Newly Diagnosed Core Binding Factor Leukemia

Compared to idarubicin, GO when added to FLAG based frontline induc…

<script src="https://fast.wistia.com/embed/medias/1yhnh9ekck.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1yhnh9ekck seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1yhnh9ekck/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:15

ASH 2018: Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients – in Real-World Clinical Practice

Real-world evidence from the Belgian registry shows that ponatinib …

<script src="https://fast.wistia.com/embed/medias/kbs3mjg440.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kbs3mjg440 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/kbs3mjg440/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:27

ASH 2018: Opsigtsvækkende resultater om CLL-behandling

I denne MEDtalk fortæller professor og overlæge Henrik Hjorth-Han…

<script src="https://fast.wistia.com/embed/medias/l2vd3j5vgi.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l2vd3j5vgi seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l2vd3j5vgi/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:37

ASH 2018: Individuel CLL-behandling er vigtigere end nogensinde

Overlege Carsten Utoft Niemann, Rigshospitalet, fortæller i denne MED…

<script src="https://fast.wistia.com/embed/medias/86wpowlp65.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_86wpowlp65 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/86wpowlp65/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:38

ASH 2018: Nye myelomatose-data giver retningen for fremtidens behandling

Agoston Gyula Szabo, der er tilknyttet Hæmatologisk Afdeling i Vejle,…

<script src="https://fast.wistia.com/embed/medias/p5xn53ffvu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p5xn53ffvu seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/p5xn53ffvu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:09

ASH 2018: Behandling af komplement-mediær sygdom

Der sker meget indenfor autoimmun hæmolytisk anæmi, og der præse…

<script src="https://fast.wistia.com/embed/medias/9u4zmywhds.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9u4zmywhds seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9u4zmywhds/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:47

ASH 2018: Gode daratumumab-data på ASH

Torben Plesner, professor, overlæge pÃ¥ Vejle sygehus, fortæller …

<script src="https://fast.wistia.com/embed/medias/ngdbkxgfvj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ngdbkxgfvj seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ngdbkxgfvj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:34

ASH 2018: Ny behandling af relaps af refraktære B-celle lymfomer

I denne MEDtalk præsenterer Martin Hutchings et nyt lægemiddel, d…

<script src="https://fast.wistia.com/embed/medias/yt06dfimie.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yt06dfimie seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yt06dfimie/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:32

ASH 2018: Stamcelletransplantation efter CAR T-Celle terapi reducerer tilbagefald ved ALL

Et nyt studie med ALL-patienter, der fÃ¥r den første stamcelletran…

<script src="https://fast.wistia.com/embed/medias/72e3qh84n7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_72e3qh84n7 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/72e3qh84n7/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:24

ASH 2018: Nyt om myelomatose fra ASH i San Diego

Overlæge Fredrik Schjesvold fra Oslo Universitetssykehus giver en …

<script src="https://fast.wistia.com/embed/medias/joiuej08zx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_joiuej08zx seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/joiuej08zx/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
14:22

Chronic Lymphocytic Leukaemia - Relapsed Treatment

Click and listen to Professor John Gribben, Barts Cancer Institute,…

<script src="https://fast.wistia.com/embed/medias/lejuvk36hb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lejuvk36hb seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lejuvk36hb/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:07

Chronic Lymphocytic Leukaemia - Upfront Treatment

CLL is an extremely heterogeneous disease, where most patients are …

<script src="https://fast.wistia.com/embed/medias/e0dud8yg8l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e0dud8yg8l seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/e0dud8yg8l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:49

ASH 2018: Stamcelle-mutationer medfører signifikant nedsat overlevelse ved aggressivt lymfom

Autolog stamcelle transplantation (ASCT) er en kurativ behandling f…

<script src="https://fast.wistia.com/embed/medias/du9o0gpjj2.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_du9o0gpjj2 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/du9o0gpjj2/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

ASH 2018: Safe and effective treatment of elderly patients with newly diagnosed Ph-negative ALL

Both the anti-CD22 antibody-drug conjugate inotuzumab ozogamicin (I…

<script src="https://fast.wistia.com/embed/medias/gldcs22ume.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gldcs22ume seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gldcs22ume/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:28

ASH 2018: Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors

In this MEDtalk Guy Young present data from HAVEN 2 – the largest p…

<script src="https://fast.wistia.com/embed/medias/ee1jrykvj1.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ee1jrykvj1 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ee1jrykvj1/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:56

PET og MDR negativitet som prognostisk markør ved follikulært lymfom

Prof. Dr. Christiane Pott fremlægger nye data fra GALLIUM-studiet, de…

<script src="https://fast.wistia.com/embed/medias/17qmz0y6h6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_17qmz0y6h6 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/17qmz0y6h6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Lovende resultater for diffus storcellet b-celle lymfom og follikulært lymfom

Polatuzumab vedotin er et konjugert antistoff som blokkerer CD79b+ cel…

<script src="https://fast.wistia.com/embed/medias/mb7jkiv0ds.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mb7jkiv0ds videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/mb7jkiv0ds/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:37

Signifikant øget PFS ved behandling af myelomatose

I fase III studiet OPTIMISMM sammenlignes 559 myelomatosepatienter med…

<script src="https://fast.wistia.com/embed/medias/srdbhz8tm1.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_srdbhz8tm1 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/srdbhz8tm1/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

Safety-data for kombinationsbehandling af AL Amyoloidose

AL amyloidose er den hyppigste subgruppe ved amyoloidose. Aflejringern…

<script src="https://fast.wistia.com/embed/medias/57ux7vp3lq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_57ux7vp3lq videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/57ux7vp3lq/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:40

Høj grad af klinisk respons ved førstelinje kombinationsbehandling af CLL.

Ved kombination af ibrutinib og obinutuzumab som førstelinjebehandlin…

<script src="https://fast.wistia.com/embed/medias/70vpn1li0t.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_70vpn1li0t videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/70vpn1li0t/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:44

CML – nyheder fra EHA 

Henrik Hjorth-Hansen, overlæge, professor, St Olavs Hospital, Trondhe…

<script src="https://fast.wistia.com/embed/medias/001wjvtrto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_001wjvtrto videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/001wjvtrto/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:19

Flere interessante studier om myeloproliferative sygdomme

Eivind Galteland, Rikshospitalet i Oslo, tager flere interessante resu…

<script src="https://fast.wistia.com/embed/medias/wi2eo7wk9d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wi2eo7wk9d videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/wi2eo7wk9d/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Nordisk studie viser, at det er muligt at bedre kronisk ITP

Waleed Ghanima, overlege ved Sykehuset Østfold, fremlægger i denne M…

<script src="https://fast.wistia.com/embed/medias/lmzj98t078.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lmzj98t078 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lmzj98t078/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

Dansk studie af lav-dosis interferon alpha vs. hydroxyurea i behandlingen af Ph-negative kroniske myeloproliferative neoplasier

DALIAH-studiet er et dansk investigator initieret klinisk randomiseret…

<script src="https://fast.wistia.com/embed/medias/4f2aq0kim5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4f2aq0kim5 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/4f2aq0kim5/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:17

Ny effektiv frontline behandling af CLL

Yngre mennesker med CLL vil mÃ¥ske kunne tilbydes en ny effektiv behan…

<script src="https://fast.wistia.com/embed/medias/xjtdj8poco.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xjtdj8poco videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xjtdj8poco/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:12

Rutinemæssig brug af Next Generation Sekventering ved CML

Resultaterne fra det første prospektive studie af rutimemæssig brug …

<script src="https://fast.wistia.com/embed/medias/di8h13na0l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_di8h13na0l videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/di8h13na0l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:46

82% opnår MDR-negativitet i first-line CLL

Ibrutinib er en sÃ¥kaldt tyrosin kinase inhibitor som hæmmer signalmo…

<script src="https://fast.wistia.com/embed/medias/pkio9zi3uz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pkio9zi3uz videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/pkio9zi3uz/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:02

Trippelbehandling til højrisiko myelomatosepatienter

Carfilzomib, cyclophosphamid and dexamethason er en effektiv og genere…

<script src="https://fast.wistia.com/embed/medias/abrvkav943.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_abrvkav943 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/abrvkav943/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:35

Tidsbegrænset behandling af højrisiko CLL-patienter med relapse

Carsten Utoft Niemann præsenterer de første meget lov…

<script src="https://fast.wistia.com/embed/medias/osig3cjt4i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_osig3cjt4i videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/osig3cjt4i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:54

Bedre behandling af kold agglutinin sygdom

Resultaterne fra et nordisk studie, fremlagt ved EHA, viser, at behand…

<script src="https://fast.wistia.com/embed/medias/h8i06fo6sd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_h8i06fo6sd videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/h8i06fo6sd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:15

Sekventering af behandling ved CLL

Selvom en lang række studier af behandling af CCL pÃ¥ begÃ¥r, sÃ¥ er …

<script src="https://fast.wistia.com/embed/medias/l3wn9ckeqd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l3wn9ckeqd videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l3wn9ckeqd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Muligt at finde CLL-patienter med risiko for immundysfunktion

Der er en del CLL-patienter, der dør som følge af infektioner. Hvis …

<script src="https://fast.wistia.com/embed/medias/xmk0lmxggu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xmk0lmxggu videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xmk0lmxggu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:02

Bedre OS-data for CLL-patienter i behandling med Gazyvaro

CLL-patienter med komorbiditet opnÃ¥r en bedre overlevelse med obinutu…

<script src="https://fast.wistia.com/embed/medias/o9zw52ytrc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o9zw52ytrc videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/o9zw52ytrc/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:06

Smouldering myeloma and high risk patients - a close look at GEM-CESAR and CENTAURUS studies (1:3)

Watch dr. Fredrik Schjesvold discuss smouldering myeloma and the tw…

<script src="https://fast.wistia.com/embed/medias/xypykci1kt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xypykci1kt videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xypykci1kt/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:29

Discussion of established combinations and new combinations in multiple myeloma (2:3)

Watch dr. Fredrik Schjesvold take you through NEW documentation for…

<script src="https://fast.wistia.com/embed/medias/7giy7ui208.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_7giy7ui208 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/7giy7ui208/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
8:49

Should all eligible patients with multiple myeloma have tandem transplant? (3:3)

Watch dr. Fredrik Schjesvold take you through the documentation in …

<script src="https://fast.wistia.com/embed/medias/fqcwho4tnv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_fqcwho4tnv videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/fqcwho4tnv/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:58

Imponerende responsrate ved B-celle lymfom

Behandling af diffust storcellet B-celle lymfom med CAR-T cell produkt…

<script src="https://fast.wistia.com/embed/medias/3xrkfabqpf.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3xrkfabqpf videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/3xrkfabqpf/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:51

Opsigtsvækkende resultater indenfor behandling af myelomatose

PÃ… ASCO 2018 blev der fremlagt flere interessante nye data i forhold …

<script src="https://fast.wistia.com/embed/medias/eghvlbohui.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_eghvlbohui videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/eghvlbohui/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:34

Flere nye interessante af CLL og CML

Professor Bjørn Tore Gjert…

<script src="https://fast.wistia.com/embed/medias/yo0hir56av.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yo0hir56av videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yo0hir56av/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:42

Bosutinib til patienter med Ph+ leukæmi

<script src="https://fast.wistia.com/embed/medias/o6zokjrin9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o6zokjrin9 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/o6zokjrin9/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:15

Hør Bruce Johnson, præsident for ASCO, fortælle om udviklingen af targeteret behandling og immunterapi

<script src="https://fast.wistia.com/embed/medias/qi5icv9l6b.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qi5icv9l6b videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/qi5icv9l6b/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:19

Hurtigere diagnostik af myelomatose

Med ganske fÃ¥ virkemidler er det muligt at afgøre, om dine patien…

<script src="https://fast.wistia.com/embed/medias/vlld4boamp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vlld4boamp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:13

CLL-highlights - flere interessante kliniske data

Klik og hør en kort redegørelse om de seneste kliniske resultater…

<script src="https://fast.wistia.com/embed/medias/u8gg77ezij.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_u8gg77ezij videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:14

Betydningen af IGHV-staus for behandling af CLL

Hør Emelie Curovic Rotbain, MD, Hæmatologisk afdeling, Rigshospit…

<script src="https://fast.wistia.com/embed/medias/gua1je7l53.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gua1je7l53 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Nivolumab - en veltolereret behandling af patienter med Hodgkin Lymfom

Nivolumab som monoterapi efterfulgt af kombinationsbehandling med nivo…

<script src="https://fast.wistia.com/embed/medias/rc3vhb4t5v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rc3vhb4t5v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

Vurdering af prognosen for CLL-patienter med B-Celle receptor stereotypi

Nye data peger frem mod en mere individuel vurdering af den enkelte pa…

<script src="https://fast.wistia.com/embed/medias/zbys3evsy5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zbys3evsy5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:27

Imponerende data om CLL

PÃ¥ flere sessioner blev der præsenteret nye resultater for behandlin…

<script src="https://fast.wistia.com/embed/medias/4h3qro4oia.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4h3qro4oia videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:08

Fortsat nivolumab-behandling ved Hodgkin lymfom

Patienter med relapse/refraktær klassisk Hodgkin lymfom behandlet me…

<script src="https://fast.wistia.com/embed/medias/gijis4ribt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gijis4ribt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:30

Nyt om kuldeagglutinin syndrom og CLL

Ny behandling er nu en mulighed, ifølge Henrik Hjorth-Hasnen, for pat…

<script src="https://fast.wistia.com/embed/medias/0evjwm7g10.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0evjwm7g10 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:29

Større følsomhed for BCL2-hæmmer ved CLL

Behandlingen af CLL er i en ny æra med flere nye behandlingsmulighede…

<script src="https://fast.wistia.com/embed/medias/qnpnm4irso.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qnpnm4irso videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:04

Risiko for dyb venetrombose og lungemboli ved cancer kan reduceres

Incidensen af venøs tromboemboli hos indlagte patienter med aktiv can…

<script src="https://fast.wistia.com/embed/medias/sgcwgexibb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sgcwgexibb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Styring af behandlingsresponset

Valg af førstelinjebehandling ved myelomatose, styring af behandli…

<script src="https://fast.wistia.com/embed/medias/hmsoa1fp2g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hmsoa1fp2g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Paradigmeskift for brug af MRD

Minimal residual disease, MRD; var fokus ved flere interessante ses…

<script src="https://fast.wistia.com/embed/medias/mcn6ssj2bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mcn6ssj2bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:48

Ophør af TKI-behandling ved CML

Varigheden af “Deep Molecular Response er den vigtigste faktor i fo…

<script src="https://fast.wistia.com/embed/medias/6gizwg2552.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6gizwg2552 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:13

Opsigtsvækkende resultater

Patienter med avanceret Hodgkin Lymfom i stadie III or IV kan med e…

<script src="https://fast.wistia.com/embed/medias/sxszhos9ye.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sxszhos9ye videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:05

Myelomatose i dansk perspektiv

Danske hæmatologer medvirkede ved to klinisk vigtig…

<script src="https://fast.wistia.com/embed/medias/gtswg4z10f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gtswg4z10f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:44

Ældre CLL-patienter får flest infektioner

Dansk registerstudie belyser forekomsten af infektioner hos patienter …

<script src="https://fast.wistia.com/embed/medias/136l423oq8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_136l423oq8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Prædiagnostisk progression af lymphocytose ved CLL

Kronisk lymfatisk leukæmi (CLL) er en heterogen sygdom der udvikle…

<script src="https://fast.wistia.com/embed/medias/sin4qn3gvn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sin4qn3gvn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:57

Behov for nye kombinationsbehandlinger for mere varig remission

Trods den bemærkelsesværdige effekt med de ny…

<script src="https://fast.wistia.com/embed/medias/4ebkzqkxps.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4ebkzqkxps videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:44

Behandlingsfri remission – et muligt nyt behandlingsmål for patienter med CML-CP

Evnen til at stoppe TKI behandling uden at miste respons (dvs.: TFR…

<script src="https://fast.wistia.com/embed/medias/mspznl86za.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mspznl86za videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:47

Ny frontline behandling til yngre CLL-patienter

I 2016 viste RESONATE-2 studiet, at Ibrutinib, Imbruvica, kan anven…

<script src="https://fast.wistia.com/embed/medias/sw991po4zb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sw991po4zb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:06

Stort fremskridt for behandling af myelomatose

Fremlæggelsen af langti…

<script src="https://fast.wistia.com/embed/medias/kmii8lc65o.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kmii8lc65o videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:06

MRD negativitet har stor klinisk betydning

Flere nye data viser, at…

<script src="https://fast.wistia.com/embed/medias/kgzgkhjdrk.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kgzgkhjdrk videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:36

Ny standard for fremtidig behandling af myelomatose

Hør Jesús F. San-Miguel fremlægge nogle de mest …

<script src="https://fast.wistia.com/embed/medias/uvpq38k04d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_uvpq38k04d videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
6:33

Behandling af follikulært lymfom

I denne MEDtalk redegør professor Andrew Davies, University af So…

<script src="https://fast.wistia.com/embed/medias/1z418ed2j3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1z418ed2j3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:55

How to treat patients in relapse following frontline ASCT

Hør professor Philippe Moreau, redegøre for to cen…

<script src="https://fast.wistia.com/embed/medias/dhhiqsxeii.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_dhhiqsxeii videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
13:24

Sequencing therapy in multiple myeloma

Hør professor Philippe Moreau, redegøre for to cen…

<script src="https://fast.wistia.com/embed/medias/9a35p1qboe.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9a35p1qboe videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Eivind Galteland og Carsten Niemann i CLL MEDtalk 13:53

Faglig diskussion om CLL behandling

Hør Carsten Niemann og Eivind Galteland diskutere to ka…

<script src="//fast.wistia.com/embed/medias/62awlmxb7f.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_62awlmxb7f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Philippe Moreau MEDtalk myelomatose 28:12

Behandling af myelomatose

Behandlingen af myelomatose er i en forrygende udvikling i disse Ã¥…

<script src="//fast.wistia.com/embed/medias/u9a8zol34b.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_u9a8zol34b videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Carsten Niemann MEDtalk KLL 23:44

Kronisk lymfatisk leukæmi - Update

Hør Carsten Niemanns opdatering pÃ¥ de danske guidelines for CLL. …

<script src="//fast.wistia.com/embed/medias/fshz4mhvr8.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_fshz4mhvr8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ASH 2017

12:06

Smouldering myeloma and high risk patients - a close look at GEM-CESAR and CENTAURUS studies (1:3)

Watch dr. Fredrik Schjesvold discuss smouldering myeloma and the tw…

<script src="https://fast.wistia.com/embed/medias/xypykci1kt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xypykci1kt videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xypykci1kt/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
12:29

Discussion of established combinations and new combinations in multiple myeloma (2:3)

Watch dr. Fredrik Schjesvold take you through NEW documentation for…

<script src="https://fast.wistia.com/embed/medias/7giy7ui208.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_7giy7ui208 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/7giy7ui208/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
8:49

Should all eligible patients with multiple myeloma have tandem transplant? (3:3)

Watch dr. Fredrik Schjesvold take you through the documentation in …

<script src="https://fast.wistia.com/embed/medias/fqcwho4tnv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_fqcwho4tnv videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/fqcwho4tnv/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:14

Betydningen af IGHV-staus for behandling af CLL

Hør Emelie Curovic Rotbain, MD, Hæmatologisk afdeling, Rigshospit…

<script src="https://fast.wistia.com/embed/medias/gua1je7l53.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gua1je7l53 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:21

Nivolumab - en veltolereret behandling af patienter med Hodgkin Lymfom

Nivolumab som monoterapi efterfulgt af kombinationsbehandling med nivo…

<script src="https://fast.wistia.com/embed/medias/rc3vhb4t5v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rc3vhb4t5v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:30

Vurdering af prognosen for CLL-patienter med B-Celle receptor stereotypi

Nye data peger frem mod en mere individuel vurdering af den enkelte pa…

<script src="https://fast.wistia.com/embed/medias/zbys3evsy5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zbys3evsy5 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:27

Imponerende data om CLL

PÃ¥ flere sessioner blev der præsenteret nye resultater for behandlin…

<script src="https://fast.wistia.com/embed/medias/4h3qro4oia.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4h3qro4oia videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:08

Fortsat nivolumab-behandling ved Hodgkin lymfom

Patienter med relapse/refraktær klassisk Hodgkin lymfom behandlet me…

<script src="https://fast.wistia.com/embed/medias/gijis4ribt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gijis4ribt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:30

Nyt om kuldeagglutinin syndrom og CLL

Ny behandling er nu en mulighed, ifølge Henrik Hjorth-Hasnen, for pat…

<script src="https://fast.wistia.com/embed/medias/0evjwm7g10.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0evjwm7g10 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:29

Større følsomhed for BCL2-hæmmer ved CLL

Behandlingen af CLL er i en ny æra med flere nye behandlingsmulighede…

<script src="https://fast.wistia.com/embed/medias/qnpnm4irso.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qnpnm4irso videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:04

Risiko for dyb venetrombose og lungemboli ved cancer kan reduceres

Incidensen af venøs tromboemboli hos indlagte patienter med aktiv can…

<script src="https://fast.wistia.com/embed/medias/sgcwgexibb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sgcwgexibb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Styring af behandlingsresponset

Valg af førstelinjebehandling ved myelomatose, styring af behandli…

<script src="https://fast.wistia.com/embed/medias/hmsoa1fp2g.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hmsoa1fp2g videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:10

Paradigmeskift for brug af MRD

Minimal residual disease, MRD; var fokus ved flere interessante ses…

<script src="https://fast.wistia.com/embed/medias/mcn6ssj2bl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mcn6ssj2bl videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:48

Ophør af TKI-behandling ved CML

Varigheden af “Deep Molecular Response er den vigtigste faktor i fo…

<script src="https://fast.wistia.com/embed/medias/6gizwg2552.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6gizwg2552 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
10:13

Opsigtsvækkende resultater

Patienter med avanceret Hodgkin Lymfom i stadie III or IV kan med e…

<script src="https://fast.wistia.com/embed/medias/sxszhos9ye.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sxszhos9ye videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
5:05

Myelomatose i dansk perspektiv

Danske hæmatologer medvirkede ved to klinisk vigtig…

<script src="https://fast.wistia.com/embed/medias/gtswg4z10f.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gtswg4z10f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:44

Ældre CLL-patienter får flest infektioner

Dansk registerstudie belyser forekomsten af infektioner hos patienter …

<script src="https://fast.wistia.com/embed/medias/136l423oq8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_136l423oq8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:18

Prædiagnostisk progression af lymphocytose ved CLL

Kronisk lymfatisk leukæmi (CLL) er en heterogen sygdom der udvikle…

<script src="https://fast.wistia.com/embed/medias/sin4qn3gvn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sin4qn3gvn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:57

Behov for nye kombinationsbehandlinger for mere varig remission

Trods den bemærkelsesværdige effekt med de ny…

<script src="https://fast.wistia.com/embed/medias/4ebkzqkxps.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4ebkzqkxps videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:44

Behandlingsfri remission – et muligt nyt behandlingsmål for patienter med CML-CP

Evnen til at stoppe TKI behandling uden at miste respons (dvs.: TFR…

<script src="https://fast.wistia.com/embed/medias/mspznl86za.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mspznl86za videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:47

Ny frontline behandling til yngre CLL-patienter

I 2016 viste RESONATE-2 studiet, at Ibrutinib, Imbruvica, kan anven…

<script src="https://fast.wistia.com/embed/medias/sw991po4zb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_sw991po4zb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:06

Stort fremskridt for behandling af myelomatose

Fremlæggelsen af langti…

<script src="https://fast.wistia.com/embed/medias/kmii8lc65o.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kmii8lc65o videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:06

MRD negativitet har stor klinisk betydning

Flere nye data viser, at…

<script src="https://fast.wistia.com/embed/medias/kgzgkhjdrk.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kgzgkhjdrk videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:36

Ny standard for fremtidig behandling af myelomatose

Hør Jesús F. San-Miguel fremlægge nogle de mest …

<script src="https://fast.wistia.com/embed/medias/uvpq38k04d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_uvpq38k04d videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ASH 2018

4:22

ASH 2018: Nyt lægemiddel mod svær Hæmofili A hos børn og unge på vej

Marianne Hoffmann, Børne-ungeklinikken, Rigshospitalet og Torben M…

<script src="https://fast.wistia.com/embed/medias/6vqk65hw5l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6vqk65hw5l seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6vqk65hw5l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:44

ASH 2018: Very exciting new data from the MURANO-study about treatment of relapsed/Refractory CLL

In this MEDtalk John Gribben, Professor, MD DSc,…

<script src="https://fast.wistia.com/embed/medias/z7n5c53sax.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_z7n5c53sax seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/z7n5c53sax/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:50

ASH 2018: Resultater fra HAVEN 3 og HAVEN 4

Hør denne MEDtalk hvor professor Víctor Jiménez Yuste, Head of H…

<script src="https://fast.wistia.com/embed/medias/f13u5no6fp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f13u5no6fp seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/f13u5no6fp/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:32

ASH 2018: ASH har oppdaget de nordiske lymfom-registere med real word evidence

I denne MEDtalk fortæller overlæge Tarec Christoffer El-Galaly, A…

<script src="https://fast.wistia.com/embed/medias/51smq4xae6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_51smq4xae6 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/51smq4xae6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:27

ASH 2018: Nyt om AML

I denne MEDtalk fortæller professor, overlæge Bjørn Tore Gjertse…

<script src="https://fast.wistia.com/embed/medias/qz64v5ds6j.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_qz64v5ds6j seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/qz64v5ds6j/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:28

ASH 2018: Forbedret PFS med ibrutinib i førstelinje til patienter over 65 år

Hør professor Kerry Rogers, The Ohio State University, fortælle o…

<script src="https://fast.wistia.com/embed/medias/vc7tnccm9i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vc7tnccm9i seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/vc7tnccm9i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:46

ASH 2018: Forbedret PFS med Ibrutinib i førstelinje i to studier

I denne MEDtalk fortæller professor Kerry Rogers, The Ohio State U…

<script src="https://fast.wistia.com/embed/medias/6navi5zsqm.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6navi5zsqm seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/6navi5zsqm/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:32

ASH 2018: Nye data for Ibrutinib sætter nye standarder for CLL-behandlingen

Professor John Gribben, Barts Cancer Institute, London, præsentere…

<script src="https://fast.wistia.com/embed/medias/iq7anw7gva.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_iq7anw7gva seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/iq7anw7gva/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:13

ASH 2018: Overbevisende resultater for Darzalex i kombination med Revlimid og Dexamethason til ældre med myelomatoise

Resultaterne fra MAIA-studiet hvor ældre patienter med myelomatose…

<script src="https://fast.wistia.com/embed/medias/43o8nlhivp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_43o8nlhivp seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/43o8nlhivp/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:33

ASH 2018: Venetoclax-Rituximab Combination Therapy in Relapsed/Refractory CLL. Update data from MURANO study

In this MEDtalk John F. Seymour present the key data from MURANO st…

<script src="https://fast.wistia.com/embed/medias/yjpdwx8lv8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yjpdwx8lv8 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yjpdwx8lv8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:01

ASH 2018: Better Early Molecular Response and relapse free survival in Newly Diagnosed Core Binding Factor Leukemia

Compared to idarubicin, GO when added to FLAG based frontline induc…

<script src="https://fast.wistia.com/embed/medias/1yhnh9ekck.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1yhnh9ekck seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1yhnh9ekck/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:15

ASH 2018: Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients – in Real-World Clinical Practice

Real-world evidence from the Belgian registry shows that ponatinib …

<script src="https://fast.wistia.com/embed/medias/kbs3mjg440.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_kbs3mjg440 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/kbs3mjg440/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:27

ASH 2018: Opsigtsvækkende resultater om CLL-behandling

I denne MEDtalk fortæller professor og overlæge Henrik Hjorth-Han…

<script src="https://fast.wistia.com/embed/medias/l2vd3j5vgi.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l2vd3j5vgi seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l2vd3j5vgi/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:37

ASH 2018: Individuel CLL-behandling er vigtigere end nogensinde

Overlege Carsten Utoft Niemann, Rigshospitalet, fortæller i denne MED…

<script src="https://fast.wistia.com/embed/medias/86wpowlp65.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_86wpowlp65 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/86wpowlp65/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:38

ASH 2018: Nye myelomatose-data giver retningen for fremtidens behandling

Agoston Gyula Szabo, der er tilknyttet Hæmatologisk Afdeling i Vejle,…

<script src="https://fast.wistia.com/embed/medias/p5xn53ffvu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p5xn53ffvu seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/p5xn53ffvu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:09

ASH 2018: Behandling af komplement-mediær sygdom

Der sker meget indenfor autoimmun hæmolytisk anæmi, og der præse…

<script src="https://fast.wistia.com/embed/medias/9u4zmywhds.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9u4zmywhds seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/9u4zmywhds/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:47

ASH 2018: Gode daratumumab-data på ASH

Torben Plesner, professor, overlæge pÃ¥ Vejle sygehus, fortæller …

<script src="https://fast.wistia.com/embed/medias/ngdbkxgfvj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ngdbkxgfvj seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ngdbkxgfvj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:34

ASH 2018: Ny behandling af relaps af refraktære B-celle lymfomer

I denne MEDtalk præsenterer Martin Hutchings et nyt lægemiddel, d…

<script src="https://fast.wistia.com/embed/medias/yt06dfimie.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_yt06dfimie seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/yt06dfimie/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:32

ASH 2018: Stamcelletransplantation efter CAR T-Celle terapi reducerer tilbagefald ved ALL

Et nyt studie med ALL-patienter, der fÃ¥r den første stamcelletran…

<script src="https://fast.wistia.com/embed/medias/72e3qh84n7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_72e3qh84n7 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/72e3qh84n7/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:24

ASH 2018: Nyt om myelomatose fra ASH i San Diego

Overlæge Fredrik Schjesvold fra Oslo Universitetssykehus giver en …

<script src="https://fast.wistia.com/embed/medias/joiuej08zx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_joiuej08zx seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/joiuej08zx/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:49

ASH 2018: Stamcelle-mutationer medfører signifikant nedsat overlevelse ved aggressivt lymfom

Autolog stamcelle transplantation (ASCT) er en kurativ behandling f…

<script src="https://fast.wistia.com/embed/medias/du9o0gpjj2.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_du9o0gpjj2 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/du9o0gpjj2/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

ASH 2018: Safe and effective treatment of elderly patients with newly diagnosed Ph-negative ALL

Both the anti-CD22 antibody-drug conjugate inotuzumab ozogamicin (I…

<script src="https://fast.wistia.com/embed/medias/gldcs22ume.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gldcs22ume seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gldcs22ume/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:28

ASH 2018: Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors

In this MEDtalk Guy Young present data from HAVEN 2 – the largest p…

<script src="https://fast.wistia.com/embed/medias/ee1jrykvj1.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ee1jrykvj1 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/ee1jrykvj1/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

EHA 2018

6:56

PET og MDR negativitet som prognostisk markør ved follikulært lymfom

Prof. Dr. Christiane Pott fremlægger nye data fra GALLIUM-studiet, de…

<script src="https://fast.wistia.com/embed/medias/17qmz0y6h6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_17qmz0y6h6 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/17qmz0y6h6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Lovende resultater for diffus storcellet b-celle lymfom og follikulært lymfom

Polatuzumab vedotin er et konjugert antistoff som blokkerer CD79b+ cel…

<script src="https://fast.wistia.com/embed/medias/mb7jkiv0ds.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_mb7jkiv0ds videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/mb7jkiv0ds/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:37

Signifikant øget PFS ved behandling af myelomatose

I fase III studiet OPTIMISMM sammenlignes 559 myelomatosepatienter med…

<script src="https://fast.wistia.com/embed/medias/srdbhz8tm1.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_srdbhz8tm1 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/srdbhz8tm1/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

Safety-data for kombinationsbehandling af AL Amyoloidose

AL amyloidose er den hyppigste subgruppe ved amyoloidose. Aflejringern…

<script src="https://fast.wistia.com/embed/medias/57ux7vp3lq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_57ux7vp3lq videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/57ux7vp3lq/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:40

Høj grad af klinisk respons ved førstelinje kombinationsbehandling af CLL.

Ved kombination af ibrutinib og obinutuzumab som førstelinjebehandlin…

<script src="https://fast.wistia.com/embed/medias/70vpn1li0t.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_70vpn1li0t videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/70vpn1li0t/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:44

CML – nyheder fra EHA 

Henrik Hjorth-Hansen, overlæge, professor, St Olavs Hospital, Trondhe…

<script src="https://fast.wistia.com/embed/medias/001wjvtrto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_001wjvtrto videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/001wjvtrto/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:19

Flere interessante studier om myeloproliferative sygdomme

Eivind Galteland, Rikshospitalet i Oslo, tager flere interessante resu…

<script src="https://fast.wistia.com/embed/medias/wi2eo7wk9d.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wi2eo7wk9d videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/wi2eo7wk9d/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Nordisk studie viser, at det er muligt at bedre kronisk ITP

Waleed Ghanima, overlege ved Sykehuset Østfold, fremlægger i denne M…

<script src="https://fast.wistia.com/embed/medias/lmzj98t078.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lmzj98t078 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lmzj98t078/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

Dansk studie af lav-dosis interferon alpha vs. hydroxyurea i behandlingen af Ph-negative kroniske myeloproliferative neoplasier

DALIAH-studiet er et dansk investigator initieret klinisk randomiseret…

<script src="https://fast.wistia.com/embed/medias/4f2aq0kim5.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4f2aq0kim5 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/4f2aq0kim5/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:17

Ny effektiv frontline behandling af CLL

Yngre mennesker med CLL vil mÃ¥ske kunne tilbydes en ny effektiv behan…

<script src="https://fast.wistia.com/embed/medias/xjtdj8poco.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xjtdj8poco videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xjtdj8poco/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:12

Rutinemæssig brug af Next Generation Sekventering ved CML

Resultaterne fra det første prospektive studie af rutimemæssig brug …

<script src="https://fast.wistia.com/embed/medias/di8h13na0l.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_di8h13na0l videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/di8h13na0l/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:46

82% opnår MDR-negativitet i first-line CLL

Ibrutinib er en sÃ¥kaldt tyrosin kinase inhibitor som hæmmer signalmo…

<script src="https://fast.wistia.com/embed/medias/pkio9zi3uz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pkio9zi3uz videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/pkio9zi3uz/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:02

Trippelbehandling til højrisiko myelomatosepatienter

Carfilzomib, cyclophosphamid and dexamethason er en effektiv og genere…

<script src="https://fast.wistia.com/embed/medias/abrvkav943.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_abrvkav943 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/abrvkav943/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:35

Tidsbegrænset behandling af højrisiko CLL-patienter med relapse

Carsten Utoft Niemann præsenterer de første meget lov…

<script src="https://fast.wistia.com/embed/medias/osig3cjt4i.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_osig3cjt4i videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/osig3cjt4i/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:54

Bedre behandling af kold agglutinin sygdom

Resultaterne fra et nordisk studie, fremlagt ved EHA, viser, at behand…

<script src="https://fast.wistia.com/embed/medias/h8i06fo6sd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_h8i06fo6sd videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/h8i06fo6sd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:15

Sekventering af behandling ved CLL

Selvom en lang række studier af behandling af CCL pÃ¥ begÃ¥r, sÃ¥ er …

<script src="https://fast.wistia.com/embed/medias/l3wn9ckeqd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l3wn9ckeqd videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l3wn9ckeqd/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:58

Muligt at finde CLL-patienter med risiko for immundysfunktion

Der er en del CLL-patienter, der dør som følge af infektioner. Hvis …

<script src="https://fast.wistia.com/embed/medias/xmk0lmxggu.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xmk0lmxggu videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/xmk0lmxggu/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:02

Bedre OS-data for CLL-patienter i behandling med Gazyvaro

CLL-patienter med komorbiditet opnÃ¥r en bedre overlevelse med obinutu…

<script src="https://fast.wistia.com/embed/medias/o9zw52ytrc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_o9zw52ytrc videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/o9zw52ytrc/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

Infektionsmedicin

9:13

Vaccination mod influenza hos rejsende

Flere steder i verden kan man blive smittet af influenza hele Ã¥ret, …

<script src="https://fast.wistia.com/embed/medias/gl6zv1zcej.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gl6zv1zcej videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gl6zv1zcej/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
6:58

Vaccination mod tyfus

Det skønnes at op mod 20 millioner mennesker Ã¥rligt rammes af tyfus…

<script src="https://fast.wistia.com/embed/medias/azud4n1pg3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_azud4n1pg3 videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/azud4n1pg3/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

Lungemedicin

16:23

Pulmonal Arteriel Hypertension, PAH - en sjælden sygdom der kan forveksles med KOL og astma

Det er vigtigt at gøre sig klart, at PAH er en lungesygdom, men sy…

<script src="https://fast.wistia.com/embed/medias/e0t83qxeha.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e0t83qxeha seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/e0t83qxeha/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:16

Oral steroids – how to use/ not use and why?

Do you agree? The use of oral steroids is always a professional dil…

<script src="https://fast.wistia.com/embed/medias/gbopfedvz8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gbopfedvz8 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gbopfedvz8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:09

How can you improve the treatment of patients with severe asthma? Choice of biological treatment?

Which asthmatic patiemts should be offered biological treatment and…

<script src="https://fast.wistia.com/embed/medias/c1tyq30fcj.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c1tyq30fcj seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/c1tyq30fcj/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:36

What is the role of eosinophils in the case of severe asthma?

Eosinophilic leucocytes play a significant role in the development …

<script src="https://fast.wistia.com/embed/medias/jkecobcnr8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jkecobcnr8 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jkecobcnr8/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:27

What are the mechanisms behind severe asthma?

Asthma should be understood more as a syndrome than as a diagnosis….

<script src="https://fast.wistia.com/embed/medias/gzvv6o4nd6.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_gzvv6o4nd6 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/gzvv6o4nd6/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:12

What significance does the phenotype have for the choice of treatment?

In recent years, treatment of asthma has become more individualized…

<script src="https://fast.wistia.com/embed/medias/anhnptlz0b.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_anhnptlz0b seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/anhnptlz0b/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>

Multipel Sklerose

2:31

ECTRIMS 2018: Tecfidera reducerer signifikant neurofilament-niveauet

I denne MEDtalks præsenterer Tobias Sejbæk Mathiesen, Sklerosekli…

<script src="https://fast.wistia.com/embed/medias/1uw1nl51x9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1uw1nl51x9 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1uw1nl51x9/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:21

ECTRIMS 2018: Interessant ny viden - men stadig meget vi ikke ved

Finn Sellebjerg, professor, Dansk Multipel Sclero…

<script src="https://fast.wistia.com/embed/medias/vyfuthunbf.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vyfuthunbf seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/vyfuthunbf/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
1:43

ECTRIMS 2018: Patienter i behandling med høj effektive præparater får færre attakker

Thor Ameri Chalmer, læge, ph.d.-stud., Det Danse Skleroseregister,…

<script src="https://fast.wistia.com/embed/medias/1dwqnc7qt9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1dwqnc7qt9 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/1dwqnc7qt9/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:50

ECTRIMS 2018: Dansk studie viser kliniske forskelle mellem Tecfidera og Aubagio

Mathias Buron, læge, ph.d. studerende, Dansk Multipel Sclerose Cen…

<script src="https://fast.wistia.com/embed/medias/05eg9m161a.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_05eg9m161a seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/05eg9m161a/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:53

ECTRIMS 2018: Større forståelse af kognitive vanskeligheder og fattigue

Sklerosepatienters kognitive vanskeligheder bør indgÃ¥ i den klini…

<script src="https://fast.wistia.com/embed/medias/i3q09hbe76.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_i3q09hbe76 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/i3q09hbe76/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:30

ECTRIMS 2018: Antistoffer mod ion-kanal øger MS-risikoen dramatisk

Undersøgelser fra det svenske MS-register viser, at antistoffer re…

<script src="https://fast.wistia.com/embed/medias/hdp9pxinvl.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hdp9pxinvl seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/hdp9pxinvl/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:12

ECTRIMS 2018: God kandidat til førstevalg ved recidiverende-remitterende MS

AUBAGIO er indiceret til behandling af voksne patienter med recidiv…

<script src="https://fast.wistia.com/embed/medias/p4mrjugra3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p4mrjugra3 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/p4mrjugra3/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:56

ECTRIMS 2018: Bedre klinisk anvendelse af biomarkører

Homayoun Roshanisefat har brugt dagene pÃ¥ ECTRIMS til at opdatere …

<script src="https://fast.wistia.com/embed/medias/pnxzohakto.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_pnxzohakto seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/pnxzohakto/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
4:10

ECTRIMS 2018: Gode kliniske erfaringer med behandlingsskift til cladribin-tabletter

Suzanne Hodgkinson associeret professor ved Sout…

<script src="https://fast.wistia.com/embed/medias/k1ekxfd66n.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_k1ekxfd66n seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/k1ekxfd66n/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
5:35

ECTRIMS 2018: Highlights for behandling med rebif og cladribin

20 Ã¥rs klinisk erfaring med rebif-behandling viser, at behnadlinge…

<script src="https://fast.wistia.com/embed/medias/c0mtrv7i44.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c0mtrv7i44 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/c0mtrv7i44/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:40

ECTRIMS 2018: Skift fra Tysabri til Lemtrada

Antonio Bertolotto chef for sklerosecenteret ved University Hospit…

<script src="https://fast.wistia.com/embed/medias/l7mtj5czup.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_l7mtj5czup seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/l7mtj5czup/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
2:52

ECTRIMS 2018: Opsigtsvækkende langtidsdata for behandling med alemtuzumab

Barry A. Singer, MD, Director…

<script src="https://fast.wistia.com/embed/medias/lv2c6ryjfo.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lv2c6ryjfo seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/lv2c6ryjfo/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
3:46

ECTRIMS 2018: Bedre metoder til at stille diagnosen og vurdere prognosen

Flere præsentationer ved ECTRIMS belyser nye og bedre metoder til…

<script src="https://fast.wistia.com/embed/medias/2hygxagnqg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_2hygxagnqg seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/2hygxagnqg/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
7:05

ECTRIMS 2018: Vedvarende mindre handikapudvikling ved behandling med ocrelizumab

Nye data fra 

<script src="https://fast.wistia.com/embed/medias/xp29ill4cd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_xp29ill4cd seo=false videoFoam=true" style="height:100%;position: